RE: TommyD8 Dec 2023 14:35
Https://www.pharmaexcipients.com/news/90-of-drugs-fail-clinical-trials/#:~:text=Analyses%20of%20clinical%20trial%20data,(10%25)2%2C4.
The institutions have poured (wasted) many £00's millions financing this lot over the years and despite the hot air, bullsh$t and bravado, SNG has barely got its first foot on the ladder with a product that so far, after many years has failed to reach any significant endpoint. So why should it all of a sudden be a hit??
The biggest mistake the BOD's made was dropping all previous research and putting all their eggs in one basket which, like it or not failed.
This stupidity has set the copmpany back at least 4 years and there is only so much patience "investors" will have with a Company like that as sadly for us all is reflected in the one thing that matters...THE SHAREPRICE.
I like many on here, took the risk nearly 4 years ago that those odds of 10/1 on SNG drug succeeding were quite attractive. Sadly although we were within reasonable distance of winning our "bet", it never quite transpired.
That though is not my gripe because, as we know, shoving money into an AIM stock has even less chance of making the grade than a pharma product and you pays your money and you takes your chance.
What I am more than disgusted with is that distain and utter contempt that Marsden and Co have treated us lot with and the total lack of communication and transparency, not exclusively, but mainly since Black Monday.
Not if, but when, the well runs dry in the not too distant future, unless there is a miracle one would imagine its bye bye Synairgen
Sign In
Follow the stocks
